Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis

Target Audience
This educational activity is directed toward cardiologists and cardiology subspecialists, nurse practitioners, physician assistants, and nurses.

Program Overview
This online, on-demand virtual symposium brings together renowned experts who treat patients with immune checkpoint inhibitor (ICI)–related cardiotoxicity. These experts will discuss underlying pathophysiologic mechanisms and best practices to monitor and treat patients with ICI-related cardiotoxicity. Patient video vignettes will highlight key points with a focus on prompt recognition, timely management, and the multidisciplinary team approach to care.

This educational activity is an archive of the live symposium held on April 2, 2022.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss the prevalence and risk factors for myocarditis and other cardiovascular immune-related adverse events (irAEs) observed with immune checkpoint inhibitor (ICI) use
Evaluate strategies for the prompt identification and diagnosis of cardiovascular irAEs among patients who receive ICI therapy
Determine best practices for the management of ICI-associated myocarditis and other cardiovascular-related irAEs
Incorporate practical multidisciplinary strategies to facilitate clinician-patient communication and counseling in settings of ICI-associated myocarditis